Andrea Douglas is the Vice President, Corporate Affairs at CSL Limited, located at CSL’s headquarters in Melbourne, Australia.
She has held various roles at CSL including leading CSL’s Organisation Transformation Office and Global R&D Strategy. Before joining CSL Andrea was the CEO of the Gene CRC and previously a senior researcher at the Walter and Eliza Hall Institute. Andrea has a PhD degree in Forensic Medicine from Monash University and holds a Master’s degree in Health Administration and is a Graduate of the Australian Institute of Company Directors. She is a Director of BioCurate and a member of the WILD Advisory Board and was a Director of AusBiotech from 2013–2019.
Andrea is Chair of the Institute’s Commercial Issues Committee.